Pulse Biosciences Inc (PLSE)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $3.71B
Last updated: Nov 17, 2026 at 11:05 AM ET
Pulse Biosciences Inc (PLSE) Stock Forecast
Analysts expect Pulse Biosciences (PLSE) to earn -$1.05 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.77M. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 1.83, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 16.7% |
| Buy | 5 | 83.3% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 157.6%.
- Fiscal year ending Dec 31, 2026
- -$1.05
- EPS consensus, revenue $1.77M
- Fiscal year ending Dec 31, 2027
- -$1.16
- EPS consensus, revenue $4.56M
- Next report
- Feb 17, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.05 | -$1.07 to -$1.02 | 3 | $1.77M | $1.60M to $1.98M | 5 |
| Dec 31, 2027 | -$1.16 | -$1.26 to -$1.11 | 4 | $4.56M | $1.60M to $7.50M | 6 |
Quarterly Estimates
The EPS consensus rises from -$0.37 for the quarter ending Dec 31, 2026 to -$0.29 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.37 | -$0.38 to -$0.37 | 8 | $632400 | $392000 to $840000 | 8 |
| Mar 31, 2027 | -$0.29 | -$0.31 to -$0.27 | 2 | $743330 | $400000 to $1.00M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$1.11.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.05 | -$1.11 | -$1.11 | -$1.11 | -$1.11 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.16 | -$1.17 | -$1.17 | -$1.16 | -$1.16 | N/A |
| Quarter ending Mar 31, 2027 | -$0.29 | -$0.31 | -$0.31 | -$0.32 | -$0.32 | N/A |
Frequently Asked Questions About PLSE
What is the PLSE stock forecast?
Consensus analyst estimates put Pulse Biosciences's EPS at -$1.05 for the fiscal year ending Dec 31, 2026, on revenue of $1.77M. The consensus rating from 6 analysts is Buy.
How do analysts rate PLSE stock?
Of 6 analysts covering Pulse Biosciences, 1 rates it Strong Buy, 5 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from PLSE next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.05, with estimates from -$1.07 to -$1.02 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.16, with estimates from -$1.26 to -$1.11 from 4 analysts.
What revenue do analysts expect from Pulse Biosciences next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.77M, with estimates from $1.60M to $1.98M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $4.56M, with estimates from $1.60M to $7.50M.
How many analysts cover PLSE?
6 analysts rate Pulse Biosciences stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PLSE pages: Overview, Earnings, Forecast, Financials, Competitors